SG Americas Securities, LLC - BIOMARIN PHARMACEUTICAL INC ownership

BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061G901. A total of 5 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q4 2017$66,000
-80.2%
71,1000.0%0.00%
-66.7%
Q3 2017$334,000
+8250.0%
71,100
+407.9%
0.00%
Q4 2016$4,000
-88.2%
14,0000.0%0.00%
Q3 2016$34,000
+61.9%
14,0000.0%0.00%
Q2 2016$21,000
-57.1%
14,0000.0%0.00%
Q1 2016$49,000
-74.9%
14,0000.0%0.00%
-100.0%
Q4 2015$195,000
-31.1%
14,0000.0%0.00%
-50.0%
Q3 2015$283,000
-42.1%
14,0000.0%0.00%
-33.3%
Q2 2015$489,000
+27.0%
14,0000.0%0.00%
+50.0%
Q1 2015$385,00014,0000.00%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q3 2023
NameSharesValueWeighting ↓
Maven Securities LTD 23,400$1,780,0000.15%
Hudson Bay Capital Management LP 70,000$5,326,0000.08%
GROUP ONE TRADING, L.P. 235,700$17,932,0000.06%
Marathon Trading Investment Management LLC 2,900$221,0000.02%
SIMPLEX TRADING, LLC 1,008$7,668,0000.01%
IMC-Chicago, LLC 16,600$1,263,0000.00%
JPMORGAN CHASE & CO 110,500$8,398,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders